# Red Blood Cell Transfusion Thresholds and QOL in MDS

> **NCT02099669** · NA · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 30 (estimated)

## Conditions studied

- Myelodysplastic Syndromes (MDS)
- Quality of Life
- Red Blood Cell (RBC) Transfusions

## Interventions

- **OTHER:** Red Blood Cell Transfusions

## Key facts

- **NCT ID:** NCT02099669
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099669, "Red Blood Cell Transfusion Thresholds and QOL in MDS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02099669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*